Cancer-30

Palliative care for advanced stage prostate cancer focuses on extending life and relieving the symptoms of metastatic disease.

As noted above Abiraterone Acetate is showing some promise in treating advance stage prostate cancer. It causes a dramatic reduction in PSA levels and Tumor sizes in aggressive advanced-stage prostate cancer for 70% of patients. Chemotherapy may be offered to slow disease progression and postpone symptoms. The most commonly used regimen combines the chemotherapeutic drug docetaxel with a corticosteroid such as prednisone. Bisphosphonates such as zoledronic acid have been shown to delay skeletal complications such as fractures or the need for radiation therapy in patients with hormone-refractory metastatic prostate cancer.

Bone pain due to metastatic disease is treated with opioid pain relievers such as morphine and oxycodone. External beam radiation therapy directed at bone metastases may provide pain relief. Injections of certain radioisotopes, such as strontium-89, phosphorus-32, or samarium-153, also target bone metastases and may help relieve pain.

All text is available under the GNU free documentation lisence

http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License

Links

Index page

Previous:  Prostate cancer - Treatment - Hormonal Therapy 2

Next:  Prostate cancer - HIFU

Find Healthcare Jobs here